SBRA Stock Cash Flow Statements

Sabra Health Care REIT Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Sabra Health Care REIT Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-09-30	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31

cash flows from operating activities:
net income	65,542,000	40,304,000	46,695,000	29,788,000	23,975,000	26,254,000	17,156,000	-15,101,000	21,188,000	-9,487,000	-84,948,000	-50,064,000	16,805,000	40,602,000	-24,353,000	10,223,000	-132,573,000	33,447,000	36,460,000	39,741,000	23,286,000	83,683,000	-77,692,000	-19,383,000	35,228,000	200,789,000	62,481,000	103,969,000	15,069,000	20,536,000	18,791,000	23,170,000	25,312,000	37,466,000	-15,743,000	25,084,000	18,034,000	16,826,000	19,439,000	22,236,000	17,198,000	14,796,000	-7,321,000	12,999,000	11,821,000	-662,000	9,557,000	3,959,000	5,226,000	5,923,000	4,405,000	7,164,000	2,343,000	2,087,000	1,248,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	43,586,000	43,494,000	42,308,000	42,720,000	41,681,000	42,914,000	42,876,000	43,242,000	44,142,000	52,827,000	49,927,000	47,427,000	45,172,000	45,256,000	45,079,000	45,046,000	44,491,000	44,375,000	44,209,000	44,032,000	43,092,000	49,476,000	44,949,000	48,078,000	48,468,000	46,828,000	48,005,000	51,592,000	25,933,000	17,220,000	19,137,000	17,199,000	17,102,000	16,405,000	17,766,000	18,126,000	16,306,000	14,497,000	14,150,000	14,465,000	9,762,000	9,755,000	9,350,000	8,555,000	8,258,000	8,222,000	8,246,000	7,907,000	7,496,000	7,557,000	7,303,000	7,364,000	6,850,000	6,291,000	6,086,000
non-cash rental and related revenues	-3,903,000	-2,428,000	-1,627,000	-433,000	-2,387,000	591,000	-1,918,000	-1,312,000	-3,071,000	-2,398,000	-2,787,000	13,031,000	-3,587,000	-4,474,000	15,710,000	20,740,000	-4,914,000	-5,713,000	7,907,000
non-cash interest income	3,000	4,000	5,000	12,000	5,000	7,000	8,000	8,000	4,000	-392,000	-602,000	-589,000	-547,000	-547,000	-544,000	-530,000	-502,000	-412,000	-608,000
non-cash interest expense	1,726,000	1,729,000	1,729,000	2,611,000	3,068,000	3,071,000	3,086,000	3,088,000	3,077,000	3,014,000	2,794,000	2,798,000	2,804,000	2,698,000	2,979,000	1,744,000	1,749,000	1,896,000	2,069,000	2,234,000	2,523,000	2,762,000	2,561,000	2,589,000	2,551,000	2,516,000	2,481,000
stock-based compensation expense	2,704,000	2,711,000	2,539,000	2,586,000	1,341,000	2,521,000	2,449,000	2,235,000	1,004,000	2,229,000	2,086,000	2,117,000	794,000	2,456,000	927,000	2,428,000	2,271,000	2,288,000	916,000	990,000	3,259,000	2,795,000	2,775,000	1,373,000	2,436,000	2,704,000	1,135,000	30,000	4,010,000	1,731,000	2,588,000	1,359,000	2,485,000	1,834,000	1,818,000	734,000	717,000	1,754,000	2,918,000	3,514,000	1,545,000	2,279,000	2,513,000	2,610,000	1,276,000	1,459,000	2,474,000	2,530,000	1,907,000	1,639,000	2,203,000	1,351,000	771,000	1,336,000	1,142,000
recovery of loan losses	-227,000	-173,000				-137,000
net gain on sales of real estate															-14,085,000	-655,000			-2,715,000	-1,084,000	19,000				-14,000
impairment of real estate			0	0	15,335,000	3,137,000	7,268,000	0	0	7,064,000	21,440,000	60,857,000			9,004,000					2,717,000	13,966,000	2,002,000	103,134,000	0	0	881,000	532,000					0	0	0	29,811,000
(income) income from unconsolidated joint ventures	-832,000	-218,000
distributions of earnings from unconsolidated joint ventures	1,654,000	2,368,000	1,693,000	1,095,000	1,181,000	1,478,000	1,764,000	593,000	745,000	367,000
other non-cash items							0				0	0
changes in operating assets and liabilities:
accounts receivable, prepaid expenses and other assets	-4,045,000	-2,822,000	-1,873,000	-4,883,000	-2,418,000	-6,288,000	-418,000	-4,383,000	-3,495,000	-2,782,000	-812,000	443,000	-617,000	-5,457,000	-4,839,000	15,423,000	512,000	-2,873,000	-2,146,000	-2,387,000	-1,963,000	4,635,000	-9,924,000	-2,722,000	-1,901,000	-472,000	-1,658,000	-10,982,000
accounts payable and accrued liabilities	-2,188,000	-4,706,000	-4,874,000	18,771,000	364,000	-21,348,000	5,331,000	11,032,000	-2,180,000	-5,839,000	-15,411,000	28,056,000	-4,927,000	-20,968,000	19,882,000	6,374,000	-785,000	-10,992,000	6,086,000	6,899,000	1,850,000	-5,354,000	-17,265,000	3,426,000	-23,177,000	7,757,000	249,000	-13,687,000	-53,897,000	4,932,000	-4,605,000	5,245,000	1,893,000	9,754,000	-5,430,000	9,387,000	-3,424,000	6,002,000	-4,988,000	-9,972,000	19,295,000	1,226,000	2,086,000	-4,983,000	8,536,000	-4,636,000	6,513,000	-5,890,000	9,125,000	-5,967,000	4,053,000	-2,165,000	7,375,000	-3,621,000	4,106,000
net cash from operating activities	80,959,000	80,263,000	79,968,000	97,650,000	80,128,000	52,795,000	78,737,000	83,216,000	70,329,000	68,289,000	67,587,000	108,463,000	76,569,000	63,114,000	97,931,000	106,193,000	83,735,000	68,531,000	96,850,000	95,494,000	85,103,000	137,919,000	53,959,000	75,519,000	71,471,000	109,906,000	101,647,000	83,715,000	-4,100,000	22,433,000	31,438,000	42,923,000	39,322,000	69,768,000	24,726,000	41,986,000	27,808,000	26,606,000	24,701,000	14,098,000	42,318,000	27,714,000	1,207,000	12,888,000	26,225,000	1,383,000	21,603,000	8,350,000	23,815,000	7,623,000	16,464,000	10,196,000	16,581,000	5,470,000	12,458,000
cash flows from investing activities:
acquisition of real estate	-53,283,000	-7,854,000	-24,205,000	-76,097,000			-38,900,000	0	0	-39,630,000	-8,219,000	-63,412,000	0	-20,573,000	-37,332,000	-9,000	-33,453,000	-28,654,000	0	-36,159,000				-22,510,000	-25,019,000	-41,981,000	-172,001,000	-26,841,000	-378,608,000
origination and fundings of loans receivable	-1,400,000	-1,710,000	-105,000	-1,788,000	-19,650,000	-102,000	-1,804,000	-564,000	-7,250,000	-1,800,000	-19,312,000								0	-3,624,000	-618,000	-6,047,000	-2,776,000	-9,283,000	-13,291,000	-14,925,000	-13,232,000	-11,597,000	-4,715,000	-419,000	-508,000	-197,000	-3,195,000	-433,000	-5,850,000	-23,480,000	-4,470,000	-14,434,000	-7,303,000	-7,141,000	-20,883,000	-18,945,000	-19,428,000
origination and fundings of preferred equity investments	0	-9,000	-303,000	-1,508,000	-14,000	-1,007,000	-8,000	-339,000	-4,292,000	-6,384,000	-2,208,000	-823,000	-916,000	-4,074,000	-4,908,000	-759,000								-28,000	-4,340,000	-17,000	-928,000	-36,000	-2,637,000	-25,000	-51,000	-503,000	-673,000	-5,188,000	-984,000
additions to real estate	-5,786,000	-7,783,000	-15,523,000	-13,829,000	-12,425,000	-12,935,000	-21,061,000	-25,799,000	-18,455,000	-19,540,000	-20,664,000	-14,314,000	-8,692,000	-10,803,000	-13,373,000	-7,542,000	-10,903,000	-10,833,000	-12,549,000	-9,466,000	-7,389,000	-3,524,000	-5,072,000	-6,002,000	-4,878,000	-5,278,000	-11,539,000	-3,721,000	-1,939,000	-774,000	-520,000	-102,000	-27,000	-400,000	-474,000	-2,093,000	-563,000	-358,000	-675,000	-320,000	-368,000	-727,000	-56,000	-376,000	-162,000			-7,000	-309,000	-474,000	-256,000		0	0	-86,000
repayments of loans receivable	5,919,000	1,129,000	775,000	1,587,000	798,000	391,000	600,000	612,000	1,918,000	6,144,000	387,000	419,000	3,770,000	696,000	517,000	1,297,000	507,000	628,000	1,485,000	4,606,000	3,659,000	4,851,000	5,251,000	3,507,000	9,395,000	10,082,000	28,805,000
repayments of preferred equity investments	556,000	813,000	622,000	595,000	4,110,000	617,000	632,000	698,000	2,697,000	1,433,000	1,203,000	2,840,000	604,000	729,000	609,000	170,000	212,000	301,000	335,000	1,407,000	1,209,000	376,000	2,087,000	379,000	6,116,000	141,000	234,000		473,000
investment in unconsolidated joint ventures	-211,000	-1,030,000	-541,000	-373,000	-156,000	-188,000	-438,000	0	0	-4,797,000
net proceeds from the sales of real estate			55,458,000	34,383,000			-600,000	79,318,000	16,645,000	152,259,000	24,488,000	22,813,000			85,657,000	6,685,000	5,179,000	3,202,000	-762,000		-1,021,000	315,879,000	6,857,000		12,663,000	271,458,000	6,743,000		5,624,000
proceeds from net investment hedges
insurance proceeds							-200,000
net cash from investing activities	-45,132,000	-16,444,000	18,560,000	-57,030,000	-57,307,000	-13,224,000	-61,779,000	59,927,000	-8,193,000	113,175,000	-31,160,000	-56,989,000	-90,857,000	-37,242,000	-258,830,000	-158,000	-41,852,000	-35,356,000	-31,550,000	-35,701,000	-19,337,000	311,535,000	6,347,000	57,759,000	-19,354,000	219,480,000	-516,379,000	63,050,000	-296,781,000	-5,380,000	-961,000	-31,190,000	-82,467,000	254,056,000	1,964,000	-86,545,000	-82,021,000	-314,423,000	-6,237,000	-33,173,000	-629,296,000	-35,864,000	-128,139,000	-260,137,000	-2,791,000	-19,270,000	-15,311,000	-97,450,000	-43,744,000	-37,247,000	-40,209,000	-11,452,000	-113,700,000	-74,019,000	-5,415,000
cash flows from financing activities:
net borrowings from revolving credit facility											56,693,000	5,000,000	125,776,000	16,577,000
principal payments on secured debt	-521,000	-517,000	-513,000	-510,000	-507,000	-503,000	-500,000	-496,000	-493,000	-490,000	-486,000	-483,000	-480,000	-16,067,000	-10,476,000	-739,000	-737,000	-709,000	-727,000	-870,000	-863,000	-854,000	-849,000	-137,136,000	-1,074,000	-1,067,000	-1,061,000	-1,051,000
payments of deferred financing costs	0	-80,000	-14,000	0	0	-80,000	-7,000	-7,000	-1,000	-18,127,000	-14,000	0	0	-6,000	-1,873,000	-7,437,000			-97,000	-1,597,000	-9,588,000	-4,407,000	-6,000	-340,000	0	-6,000	-6,000	-21,000	-15,192,000	-15,000	-109,000	-4,000	-2,000	-46,000	-5,885,000	-138,000	-480,000	-704,000	-130,000	-3,657,000	-5,339,000	-262,000	-9,873,000	-356,000	-3,220,000	-5,306,000	-72,000	245,000	-3,610,000	-979,000	-2,456,000	-182,000	-225,000	36,000	-306,000
issuance of common stock	29,602,000	-5,391,000	14,759,000	34,959,000	39,009,000	-2,606,000	-488,000	-41,000	-306,000	-1,847,000	-416,000	-591,000	-55,000	-3,748,000	136,525,000	-510,000	85,044,000	87,654,000	19,101,000	247,298,000	90,455,000	213,898,000	-2,323,000	0	0	0	-499,000	47,774,000	322,250,000	0	-3,224,000	0	0	-15,000	-1,274,000	-214,000	-445,000	147,649,000	-7,587,000	280,322,000	9,926,000	220,547,000	-648,000	37,467,000	-99,000	-317,000	-2,534,000	-91,000	0			-189,000	162,884,000
dividends paid on common stock	-71,381,000	-71,373,000	-70,976,000	-70,280,000	-69,450,000	-69,444,000	-69,368,000	-69,368,000	-69,360,000	-69,351,000	-69,296,000	-69,296,000	-69,290,000	-69,275,000	-68,608,000	-66,261,000	-64,829,000	-63,221,000	-61,679,000
net cash from financing activities	36,725,000	-101,242,000	-100,964,000	-13,955,000	-46,413,000	-20,229,000	-9,363,000	-136,393,000	-68,473,000	-196,071,000	-13,519,000	-91,620,000	55,951,000	-112,519,000	-274,628,000	371,573,000	2,471,000	-69,276,000	-60,402,000	-50,447,000	-83,489,000	-424,770,000	-87,474,000	-212,753,000	-138,351,000	-161,805,000	-114,392,000	341,014,000	317,891,000	-16,741,000	-43,347,000	-4,997,000	-41,693,000	-229,086,000	-25,122,000	20,601,000	79,690,000	289,873,000	-76,086,000	55,389,000	597,372,000	18,949,000	126,910,000	154,916,000	-19,563,000	57,092,000	30,172,000	75,724,000	47,296,000	30,059,000	-15,830,000	-12,911,000	150,082,000	-8,207,000	-1,066,000
net increase in cash, cash equivalents and restricted cash	72,552,000	-37,423,000	-2,436,000			19,342,000					22,908,000	-40,146,000			-435,527,000	477,608,000	44,354,000	-36,101,000						-79,475,000
effect of foreign currency translation on cash, cash equivalents and restricted cash	203,000	-19,000	-201,000	2,000	-29,000	-131,000	266,000	-272,000	33,000	-641,000	-124,000	-227,000	579,000	40,000	-5,000	-125,000	94,000	65,000	146,000	135,000	-89,000	151,000	149,000	-383,000	96,000	-97,000	-155,000
cash, cash equivalents and restricted cash, beginning of period	0	66,339,000	0	0	0	46,719,000	0	0	0	53,932,000	0	0	0	115,886,000	0	0	0	65,523,000	0	0	0	0	59,658,000	0	0	0	587,449,000
cash, cash equivalents and restricted cash, end of period	72,755,000	28,897,000	-2,637,000	26,667,000	-23,621,000	65,930,000	7,861,000	6,478,000	-6,304,000	38,684,000	22,784,000	-40,373,000	42,242,000	29,279,000	-435,532,000	477,483,000	44,448,000	29,487,000	5,044,000	9,481,000	-17,812,000	24,835,000	32,639,000	-79,858,000	-86,138,000	167,484,000	58,170,000
supplemental disclosure of cash flow information:
interest paid	29,514,000	20,233,000		20,785,000	30,352,000	20,495,000		20,320,000	30,273,000	22,318,000		18,810,000	31,585,000	18,383,000		20,393,000	24,038,000	21,620,000	20,328,000		25,599,000	32,436,000	42,195,000		43,726,000	25,170,000	42,623,000		19,892,000	10,817,000	18,127,000	10,225,000	18,428,000	11,122,000	19,459,000	10,470,000	17,964,000	8,680,000	16,761,000	7,763,000	11,407,000	8,079,000	7,219,000	16,604,000	2,098,000	16,775,000	3,064,000	15,497,000	2,439,000	12,537,000	2,140,000	11,533,000	2,548,000	12,029,000	2,447,000
net (repayments of) borrowings from revolving credit facility		-23,881,000					61,000,000	-66,481,000	19,585,000	-118,442,000
loss on extinguishment of debt							0	0	0	1,541,000	0	140,000	0	271,000	32,862,000	913,000	54,000	793,000	139,000	5,577,000	644,000							0				0	0	0	556,000					0	158,000	80,000	1,338,000		350,000
(recovery of) benefit from loan losses			-125,000	-148,000
net (gain) loss on sales of real estate																		-1,313,000										-47,415,000	-582,000
other-than-temporary impairment of unconsolidated joint ventures
income from unconsolidated joint ventures			96,000	-214,000	-80,000	595,000	761,000	645,000	653,000	838,000	30,539,000	4,384,000
escrow deposits for potential investments											56,000	0	2,381,000	-3,217,000
deposits for potential sale of real estate
net proceeds from sales-type lease							0	0	0	25,490,000
distributions in excess of earnings from unconsolidated joint ventures							0	0
net borrowings from (repayments of) revolving credit facility			-44,220,000	21,876,000	-15,465,000	52,404,000													-17,000,000
proceeds from term loans							0	0	2,000	12,186,000																		0					0	0	69,360,000
principal payments on term loans											0	-23,750,000	0	-40,000,000	0	-345,000,000	-17,000,000	-93,000,000
payment of contingent consideration							0	0			0
net income on sales of real estate								46,545,000	7,833,000	21,515,000		80,000											1,520,000				472,000								4,602,000
supplemental disclosure of non-cash investing activities:
decrease in loans receivable and other investments due to acquisition of real estate								0	0	4,644,000		8,688,000	0	5,623,000					0
net decrease in cash, cash equivalents and restricted cash								6,750,000	-6,337,000	-14,607,000				-86,647,000					4,898,000		-17,723,000	24,684,000	-27,168,000			167,581,000	-529,124,000
benefit from loan losses and other reserves									429,000	-208,000			-270,000	475,000	2,045,000	-26,000	-109,000	2,025,000	-90,000
proceeds from issuance of senior unsecured notes															0					341,740,000	-2,961,000																			149,250,000	0	0	350,000,000	0	0			0
principal payments on senior unsecured notes																				-200,000,000	0																			0	0	0	-211,250,000	0	0
payments related to extinguishment of debt																				-3,605,000	-2,000
benefit from (recovery of) loan losses and other reserves
(recovery of) benefit from loan losses and other reserves
other-than-temporary impairment of unconsolidated joint venture															0	0
investment in unconsolidated joint venture												-12,000												0	0	0	-354,461,000
income from unconsolidated joint venture														2,802,000	13,264,000	4,018,000	5,663,000	5,010,000	-2,766,000	1,161,000	605,000			1,805,000	1,725,000	2,347,000	-446,000
non-cash lease termination income																				-854,000	0
distributions of earnings from unconsolidated joint venture																			4,235,000	3,703,000	3,278,000	3,847,000	3,037,000	2,416,000	2,884,000
distributions in excess of earnings from unconsolidated joint venture																			0
net repayments of revolving credit facility																							-4,000,000				-30,000,000				-9,000,000				-57,000,000
distributions to noncontrolling interest
secured debt assumed by buyer in connection with sale of real estate
buyout of noncontrolling interests
secured debt assumed by buyers in connection with sales of real estate
benefit from doubtful accounts, straight-line rental income and loan losses																				-219,000	57,000	193,000	1,207,000
change in fair value of contingent consideration																												126,000	270,000	0	-822,000	-1,576,000	100,000			-1,850,000	100,000	100,000	100,000	-700,000	100,000	-660,000	-300,000	-400,000	-300,000	1,400,000	-500,000
cash received in ccp merger																												1,000
net proceeds from sales of real estate
net (repayments of) proceeds from revolving credit facility																																26,000,000	0
distributions to noncontrolling interests																				-200,000	-43,000	-37,000	-36,000	-35,000	-35,000	-35,000	-37,000
preferred stock redemption																								0	0
dividends paid on common and preferred stock																				-88,213,000	-85,487,000	-81,475,000	-80,260,000	-80,242,000	-80,242,000	-81,947,000	-82,789,000	-95,276,000	-26,122,000	-30,698,000	-29,993,000	-29,981,000	-29,995,000	-29,987,000	-29,301,000	-29,278,000	-29,276,000	-25,671,000	-25,672,000	-23,835,000	-20,529,000	-20,528,000	-16,597,000	-15,474,000	-15,268,000
amortization of above and below market lease intangibles																					-1,601,000	-1,601,000	4,304,000	3,508,000	5,561,000	-684,000	-684,000	-1,549,000
non-cash interest income adjustments																					-555,000	-563,000	-562,000	-578,000	-548,000	-604,000	-570,000	-632,000	-188,000	25,000	26,000	33,000	106,000	221,000	222,000	283,000	131,000	99,000	113,000	108,000	77,000	70,000	70,000	50,000	17,000	7,000	5,000	6,000	9,000
straight-line rental income adjustments																					-3,357,000	-5,242,000	-5,468,000	-9,740,000	-10,652,000	-12,189,000	-11,563,000	-11,180,000	-8,682,000	-4,971,000	-4,607,000	-5,274,000	-5,593,000	-5,524,000	-5,593,000	-6,048,000	-6,438,000	-6,178,000	-5,656,000	-6,747,000	-4,641,000	-4,247,000	-4,186,000	-3,873,000	-3,536,000	-3,617,000	-3,683,000	-2,036,000	-1,167,000	-721,000	-969,000	-1,372,000	-592,000
loss (income) from unconsolidated joint venture																							1,383,000
benefit from doubtful accounts and loan losses																									8,910,000	-674,000	1,213,000	9,659,000	5,149,000	535,000	1,770,000	2,257,000	540,000	223,000	2,523,000
supplemental disclosure of non-cash investing and financing activities:
acquisition of business in ccp merger
assumption of indebtedness in ccp merger
stock exchanged in ccp merger
gain on consolidation
restricted cash																												-1,285,000	-3,167,000	-1,138,000	-731,000	-877,000	-588,000	-1,078,000	-1,154,000	-884,000	-1,528,000	-951,000	-599,000	-1,284,000	-758,000	-388,000	-1,202,000	-855,000	-938,000	-869,000	-1,063,000	-906,000	-706,000	-1,041,000	-967,000	-1,042,000	-1,012,000	-819,000	-1,006,000
repayment of loans receivable																												23,720,000	7,163,000	1,429,000	118,000	1,015,000	21,054,000	185,019,000	8,874,000	2,518,000	1,233,000	0	2,052,000	810,000
repayment of preferred equity investments
release of contingent consideration held in escrow																																				0	0
net proceeds from sale of real estate
net proceeds from (repayments of) revolving credit facility
proceeds from secured debt
contributions by noncontrolling interests
net increase in cash and cash equivalents																												487,779,000	17,010,000	312,000	-12,870,000	6,736,000	-84,838,000	94,738,000	1,568,000	-23,958,000	25,477,000			36,314,000	10,394,000	10,799,000	-22,000		3,871,000	39,205,000	36,464,000				-39,575,000				5,977,000
effect of foreign currency translation on cash and cash equivalents																												-20,000	628,000	109,000	21,000	-747,000	644,000	-3,000	131,000	-81,000	-46,000
cash and cash equivalents, beginning of period																												0	0	0	25,663,000	0	0	0	7,434,000	0	0	0	61,793,000	0	0	0	4,308,000	0	0	0	17,101,000	0	0	0	42,250,000	0	0	0	74,233,000
cash and cash equivalents, end of period																												487,759,000	17,638,000	421,000	12,814,000	5,989,000	-84,194,000	94,735,000	9,133,000	-24,039,000	25,431,000	1,871,000	4,171,000	36,314,000	10,394,000	10,799,000	4,286,000	-92,333,000	3,871,000	39,205,000	53,565,000	-13,376,000	27,367,000	435,000	2,675,000	-14,167,000	52,963,000	-76,756,000	80,210,000
amortization of deferred financing costs																													1,574,000	1,281,000	1,277,000	1,273,000	1,273,000	1,273,000	1,221,000	1,314,000	1,300,000	1,268,000	1,261,000	1,233,000	940,000	927,000	945,000	885,000	806,000	823,000	766,000	1,180,000	1,173,000	881,000	566,000	491,000	512,000	500,000	495,000
amortization of debt premium/discount
real estate acquired through loan receivable foreclosure																																0
amortization of debt discount																														29,000	28,000	28,000	27,000	27,000	27,000	26,000	26,000
prepaid expenses and other assets																														-13,715,000	-1,414,000	-2,833,000	-1,884,000	9,165,000	-5,900,000	-7,759,000	-3,743,000	-8,086,000	-3,206,000	-5,464,000	-1,358,000	981,000	-2,152,000	-1,965,000	69,000	-1,050,000	-513,000	-198,000	895,000	-653,000	-126,000	-1,591,000	337,000	-172,000	391,000
net borrowing (repayments) of revolving credit facility
principal payments on mortgage notes																														-1,028,000	-1,021,000	-1,012,000	-11,696,000	-1,038,000	-1,022,000	-948,000	-844,000	-643,000	-697,000	-691,000	-686,000	-30,408,000	-57,325,000	-913,000	-888,000
net proceeds from the sale of real estate																																	9,993,000	75,058,000	398,000		13,952,000								0	0	2,208,000
acquisitions of real estate																																-43,960,000				-74,758,000	-84,721,000			-49,600,000	-603,490,000	-9,739,000	-108,650,000	-119,780,000	0			-107,374,000	-42,500,000	-25,700,000	-29,850,000	-16,800,000	-113,700,000
proceeds from term loan																																				0	0
proceeds from mortgage notes																																				0				0	0	11,600,000	46,103,000
assumption of mortgage indebtedness																																				10,779,000	0			0	0
increase in real estate investments due to variable interest consolidation
decrease in loans receivable and preferred equity due to variable interest consolidation
decrease in loans receivables/increase in real estate
dip loan fundings
net proceeds from revolving credit facility																																				51,000,000
issuance of preferred stock																																												-8,000	-88,000	-638,000	138,983,000
supplemental disclosure of non-cash transactions:
benefit from doubtful accounts and write-offs																																					2,489,000
preferred equity investments																																					-4,150,000	-4,820,000	-311,000
gain on sale of real estate
net proceeds (repayments) from revolving credit facility
amortization of premium																																							25,000	23,000	0	0	-33,000	-136,000	-134,000
benefit from doubtful accounts																																							1,144,000
write-off of straight-line rental income																																								0	0	2,895,000	99,000
net (repayments) proceeds from revolving credit facility																																							-42,000,000
net decrease in cash and cash equivalents																																							-57,622,000										27,367,000				52,963,000
impairment charge
decrease in preferred equity investment/increase in loans receivable
preferred equity investment																																									-4,842,000	-6,453,000	-5,000		-1,480,000	-498,000	-4,646,000
proceeds from revolving credit facility
payments on revolving credit facility
supplemental disclosure of non-cash transaction:
proceeds from secured revolving credit facility																																										30,000,000	50,000,000					92,500,000	0
payments on secured revolving credit facility																																										-192,000,000	-23,500,000	-8,000,000	0	0	-92,500,000	0
non-cash loss on extinguishment of debt
origination of loans receivable																																												-139,567,000	-1,149,000	-12,371,000	-12,873,000	-69,000	-935,000
acquisition of note receivable																																																				0	0	-19,000	-5,329,000
repayment of note receivable
proceeds from sale of real estate
amortization of premium on notes payable																																																-488,000	-4,000	-4,000	-4,000	-4,000	-3,000	-4,000	-4,000
amortization of premium on senior unsecured notes																																															-199,000	-195,000
principal payments on mortgage notes payable																																															-989,000	-25,525,000	-14,237,000	-21,673,000	-791,000	-778,000	-750,000	-739,000	-760,000
dividends paid																																															-12,716,000	-12,227,000	-12,239,000	-12,250,000	-12,213,000	-11,762,000	-11,827,000
deferred taxes
cash received in the separation
proceeds from mortgage notes payable																																																20,822,000
payment of separation-related obligations
proceeds from mortgage notes payables
origination of note receivable																																																			-10,103,000
payments related to the issuance of common stock																																																			-370,000
additions to corporate furniture, fixtures and equipment
net non-cash assets received in the separation

We provide you with 20 years of cash flow statements for Sabra Health Care REIT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sabra Health Care REIT stock. Explore the full financial landscape of Sabra Health Care REIT stock with our expertly curated income statements.

The information provided in this report about Sabra Health Care REIT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.